Stay tuned and learn Genekor’s latest news and updates on Molecular Oncology.



RxPONDER Study Results Demonstrate that the Oncotype DX®
Test Can Now Spare Chemotherapy Use in the Majority of Women
with Node-positive Early-stage Breast Cancer.

read more

The New Molecular Assay by Genekor Medical S.A. - PrIMe.

PrIMe assay is a 500+ Gene panel- test that also analyses immunotherapy biomarkers MSI, TMB and PD-L1. It is one of the most detailed, sensitive and specific tests for the tumor biology configuration, enabling physicians to plan an efficient targeted treatment plan for the patient, including immuotherapies. 

read more

Choosing my medication based on my DNA?

A new molecular test, called MyTheragene, which is performed once in our lives and based on the science of pharmacogenomics, provides the answers between 500 different drugs, making it easier for the doctor and patient to choose a safe, individualized and effective treatment with obvious benefits for the patient.

read more

1/12 - World AIDS day

Each year, on 1 December, the world commemorates World AIDS Day. People around the world unite to show support for people living with HIV and to remember those who have died from AIDS-related illnesses. The theme of this year's World AIDS Day is "Communities make the difference".

read more

Cancer Biomarkers: Discovering the present, shaping the future

A tumor marker is anything present in or produced by cancer cells or other cells of the body in response to cancer or certain benign (noncancerous) conditions that provides information about a cancer, such as how aggressive it is, whether it can be treated with a targeted therapy, or whether it is responding to treatment.

read more
Change cookies consent Revoke cookies consent